Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.

Gallenga, P E

Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study. [electronic resource] - Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 1999 - 250-7 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0030-3755

10.1159/000027430 doi


Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents--administration & dosage
Anti-Infective Agents--administration & dosage
Bacteria--drug effects
Child
Colony Count, Microbial
Conjunctiva--microbiology
Conjunctivitis, Bacterial--drug therapy
Double-Blind Method
Female
Fluoroquinolones
Follow-Up Studies
Haemophilus Infections--drug therapy
Humans
Male
Middle Aged
Ophthalmic Solutions
Prospective Studies
Quinolones--administration & dosage
Staphylococcal Infections--drug therapy
Streptococcal Infections--drug therapy
Tobramycin--administration & dosage
Treatment Outcome